PEP
51
-5
MMC
53
-12
MKC
66
-2
RRC
65
2
SJM
28
-6
NTAP
37
2
CCL
40
3
PSX
42
17
WMB
55
4
WDC
35
3
K
59
2
O
39
2
SWK
34
-12
GOOGL
45
5
HOG
40
-5
FOXA
52
2
VTR
54
2
CF
35
3
CTSH
38
-2
CAH
51
4
PEP
51
-5
MMC
53
-12
MKC
66
-2
RRC
65
2
SJM
28
-6
NTAP
37
2
CCL
40
3
PSX
42
17
WMB
55
4
WDC
35
3
K
59
2
O
39
2
SWK
34
-12
GOOGL
45
5
HOG
40
-5
FOXA
52
2
VTR
54
2
CF
35
3
CTSH
38
-2
CAH
51
4
Financhill
Back

Schlumberger Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
45

SLB
Schlumberger

Last Price:
$40.07
Seasonality Move:
6.24%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$97.77
Seasonality Move:
6.73%
Sell
45
Schlumberger (SLB) is a Sell

Is Schlumberger a Buy, Sell or Hold?

  • The current Schlumberger [SLB] share price is $40.05. The Score for SLB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • SLB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SLB Stock Price Chart

What is Schlumberger's stock price today?

  • The Schlumberger share price today is $40.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLB is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

SLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 45.63 Sell
Chaikin Money Flow: -3048260 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.97 - 41.91) Sell
Bollinger Bands (100): (39.29 - 43.19) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

SLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.16 Sell
20-day SMA: 41.06 Sell
50-day SMA: 40.53 Sell
200-day SMA: 43.02 Sell
8-day EMA: 40.31 Sell
20-day EMA: 40.67 Sell
50-day EMA: 40.87 Sell
200-day EMA: 43.25 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Schlumberger Earnings Growth & SLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.08 per share, and an increase next year of $0.38 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Schlumberger Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):